BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/21/2021 9:30:52 AM | Browse: 16 | Download: 23
Publication Name World Journal of Clinical Oncology
Manuscript ID 65070
Country/Territory Lebanon
2021-02-27 11:51
Peer-Review Started
2021-02-27 12:01
To Make the First Decision
Return for Revision
2021-03-31 04:49
2021-04-11 16:18
Second Decision
2021-06-18 08:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-06-18 11:41
Articles in Press
2021-06-18 11:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-06-25 20:58
Typeset the Manuscript
2021-07-20 04:43
Publish the Manuscript Online
2021-07-21 09:30
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells
Manuscript Source Invited Manuscript
All Author List Zaynab Fatfat, Maamoun Fatfat and Hala Gali-Muhtasib
Author(s) ORCID Number
Zaynab Fatfat http://orcid.org/0000-0003-1254-0648
Maamoun Fatfat http://orcid.org/0000-0001-9642-6708
Hala Gali-Muhtasib http://orcid.org/0000-0001-6840-3015
Funding Agency and Grant Number
Corresponding Author Hala Gali-Muhtasib, PhD, Professor, Department of Biology, American University of Beirut, Bliss Street, Beirut 1107 2020, Lebanon. amro@aub.edu.lb
Key Words Thymoquinone; Combination therapy; Cancer cells; Cancer stem cells; Conventional cancer therapy; Natural products
Core Tip There has been great interest in integrating thymoquinone (TQ) in combination therapy particularly to target cancer stem cells which are known to be responsible for resistance to treatment and cancer recurrence. The combination of TQ with standard chemotherapeutics and other natural products has exhibited promising anticancer responses. TQ was also shown to sensitize cancer cells to radiotherapy and help in overcoming major limitations that restrict the potency of chemotherapy which are chemoresistance and treatment associated toxic effects.
Publish Date 2021-07-21 09:30
Citation Fatfat Z, Fatfat M, Gali-Muhtasib H. Therapeutic potential of Thymoquinone in combination therapy against cancer and cancer stem cells. World J Clin Oncol 2021; 12(7): 522-543
URL https://www.wjgnet.com/2218-4333/full/v12/i7/522.htm
DOI https://dx.doi.org/10.5306/wjco.v12.i7.522
Full Article (PDF) WJCO-12-522.pdf
Full Article (Word) WJCO-12-522.docx
Manuscript File 65070-Review-Filipodia-CL.docx
Answering Reviewers 65070-Answering reviewers.pdf
Audio Core Tip 65070-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 65070-Conflict-of-interest statement.pdf
Copyright License Agreement 65070-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 65070-Language certificate.pdf
Peer-review Report 65070-Peer-review(s).pdf
Scientific Misconduct Check 65070-Scientific misconduct check.pdf
Scientific Editor Work List 65070-Scientific editor work list.pdf